172 related articles for article (PubMed ID: 38423851)
21. Rhabdomyosarcoma and other soft tissue sarcomas in children.
Pappo AS
Curr Opin Oncol; 1996 Jul; 8(4):311-6. PubMed ID: 8869806
[TBL] [Abstract][Full Text] [Related]
22. Radiomic features as biomarkers of soft tissue paediatric sarcomas: preliminary results of a PET/MR study.
Giraudo C; Fichera G; Stramare R; Bisogno G; Motta R; Evangelista L; Cecchin D; Zucchetta P
Radiol Oncol; 2022 Mar; 56(2):138-141. PubMed ID: 35344641
[TBL] [Abstract][Full Text] [Related]
23. The treatment approach to pediatric non-rhabdomyosarcoma soft tissue sarcomas: a critical review from the INternational Soft Tissue SaRcoma ConsorTium.
Ferrari A; Orbach D; Sparber-Sauer M; Walterhouse DO; Pajtler KW; Meyer WH; Spunt SL; Weiss AR
Eur J Cancer; 2022 Jul; 169():10-19. PubMed ID: 35490564
[TBL] [Abstract][Full Text] [Related]
24. Metastatic adult-type non-rhabdomyosarcoma soft tissue sarcomas in children and adolescents: A cohort study from the European paediatric Soft tissue sarcoma Study Group.
Ferrari A; Orbach D; Casanova M; van Noesel MM; Berlanga P; Brennan B; Corradini N; Schoot RA; Ramirez-Villar GL; Hjalgrim LL; Alaggio R; Guillen Burrieza G; Safwat A; Cameron AL; van Rijn RR; Minard-Colin V; Zanetti I; Bisogno G; Chisholm JC; Merks JHM
Cancer; 2023 Aug; 129(16):2542-2552. PubMed ID: 37084075
[TBL] [Abstract][Full Text] [Related]
25. Soft tissue sarcomas in children.
Kapoor G; Das K
Indian J Pediatr; 2012 Jul; 79(7):936-42. PubMed ID: 21935710
[TBL] [Abstract][Full Text] [Related]
26. Retrospective audit of 957 consecutive
Macpherson RE; Pratap S; Tyrrell H; Khonsari M; Wilson S; Gibbons M; Whitwell D; Giele H; Critchley P; Cogswell L; Trent S; Athanasou N; Bradley KM; Hassan AB
Clin Sarcoma Res; 2018; 8():9. PubMed ID: 30116519
[TBL] [Abstract][Full Text] [Related]
27. Clinical features and outcomes of infantile soft-tissue sarcoma: A multicenter retrospective study in Beijing.
Zhu S; Xu N; Zhi T; Gao Y; Zhong D; Zhang W; Jin M; Sun Q; Xie Y; Zhang X; Li L; Wang S; Wang H; Liu R; Zhao W; Huang D; Ni X; Ma X
J Cancer Res Ther; 2023 Aug; 19(4):876-880. PubMed ID: 37675711
[TBL] [Abstract][Full Text] [Related]
28. Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas.
Schwarzbach MH; Dimitrakopoulou-Strauss A; Willeke F; Hinz U; Strauss LG; Zhang YM; Mechtersheimer G; Attigah N; Lehnert T; Herfarth C
Ann Surg; 2000 Mar; 231(3):380-6. PubMed ID: 10714631
[TBL] [Abstract][Full Text] [Related]
29. Imaging and response in soft tissue sarcomas.
Schuetze SM
Hematol Oncol Clin North Am; 2005 Jun; 19(3):471-87, vi. PubMed ID: 15939192
[TBL] [Abstract][Full Text] [Related]
30. Multidisciplinary management of pediatric soft-tissue sarcoma.
Neville HL; Raney RB; Andrassy RJ; Cooley DA
Oncology (Williston Park); 2000 Oct; 14(10):1471-81; discussion 1482-6, 1489-90. PubMed ID: 11098512
[TBL] [Abstract][Full Text] [Related]
31. FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases.
Charest M; Hickeson M; Lisbona R; Novales-Diaz JA; Derbekyan V; Turcotte RE
Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1944-51. PubMed ID: 19593561
[TBL] [Abstract][Full Text] [Related]
32. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
Sheikhbahaei S; Marcus C; Hafezi-Nejad N; Taghipour M; Subramaniam RM
PET Clin; 2015 Jul; 10(3):375-93. PubMed ID: 26099673
[TBL] [Abstract][Full Text] [Related]
33. PET-CT in the Evaluation of Neoadjuvant/Adjuvant Treatment Response of Soft-tissue Sarcomas: A Comprehensive Review of the Literature.
Castillo-Flores S; Gonzalez MR; Bryce-Alberti M; de Souza F; Subhawong TK; Kuker R; Pretell-Mazzini J
JBJS Rev; 2022 Dec; 10(12):. PubMed ID: 36639875
[TBL] [Abstract][Full Text] [Related]
34. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.
Ruymann FB; Grovas AC
Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991
[TBL] [Abstract][Full Text] [Related]
35. Overview of the clinical and imaging features of the most common non-rhabdomyosarcoma soft-tissue sarcomas.
Kao SC
Pediatr Radiol; 2019 Oct; 49(11):1524-1533. PubMed ID: 31620852
[TBL] [Abstract][Full Text] [Related]
36. [Soft tissue sarcoma: how can posttreatment alterations be distinguished from recurrences?].
Noebauer-Huhmann IM; Grieser T
Radiologe; 2017 Nov; 57(11):923-937. PubMed ID: 29038992
[TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node biopsy in pediatric soft tissue sarcoma patients: utility and concordance with imaging.
Alcorn KM; Deans KJ; Congeni A; Sulkowski JP; Bagatell R; Mattei P; Minneci PC
J Pediatr Surg; 2013 Sep; 48(9):1903-6. PubMed ID: 24074665
[TBL] [Abstract][Full Text] [Related]
38. Local control of parameningeal rhabdomyosarcoma: An expert consensus guideline from the International Soft Tissue Sarcoma Consortium (INSTRuCT).
Casey DL; Mandeville H; Bradley JA; Ter Horst SAJ; Sheyn A; Timmermann B; Wolden SL
Pediatr Blood Cancer; 2022 Jul; 69(7):e29751. PubMed ID: 35484997
[TBL] [Abstract][Full Text] [Related]
39. PET/Computed Tomography and Precision Medicine: Musculoskeletal Sarcoma.
Kandathil A; Subramaniam RM
PET Clin; 2017 Oct; 12(4):475-488. PubMed ID: 28867117
[TBL] [Abstract][Full Text] [Related]
40. [Is FDG TEP CT practice changing in the management of sarcomas in adults?].
Kogay M; Thariat J; Benisvy D; Dufour M; Gastaud L; Saada E; Iannessi A; Thyss A
Bull Cancer; 2016 Sep; 103(9):735-42. PubMed ID: 27452925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
